Sugammadex Sodium Patent Expiration
Sugammadex Sodium is Used for reversing drug-induced neuromuscular blockage. It was first introduced by Merck Sharp And Dohme Llc A Sub Of Merck And Co Inc
Sugammadex Sodium Patents
Given below is the list of patents protecting Sugammadex Sodium, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Bridion | US6949527 | 6-Mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block |
Jan 27, 2021
(Expired) | Msd Sub Merck |
| Bridion | US7265009 | HDP-CVD methodology for forming PMD layer |
Aug 07, 2020
(Expired) | Msd Sub Merck |
| Bridion | US7265099 | Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
Aug 07, 2020
(Expired) | Msd Sub Merck |
| Bridion | USRE44733 | 6-mercapto-cyclodextrin derivatives:reversal agents for drug-induced neuromuscular block | Jan 27, 2026 | Msd Sub Merck |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Sugammadex Sodium Generics
Several generic applications have been filed for Sugammadex Sodium. The first generic version for Sugammadex Sodium was by Aspiro Pharma Ltd and was approved on Jun 9, 2023. And the latest generic version is by Zydus Pharmaceuticals Usa Inc and was approved on Oct 4, 2023.
Given below is the list of companies who have filed for Sugammadex Sodium generic.
1. ASPIRO
Aspiro Pharma Ltd has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Aspiro.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Jun 9, 2023 |
| EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Jun 9, 2023 |
2. SANDOZ
Sandoz Inc has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Sandoz.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Jun 23, 2023 |
| EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Jun 23, 2023 |
3. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Jun 15, 2023 |
| EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | solution | Prescription | INTRAVENOUS | AP | Jun 15, 2023 |
4. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Sugammadex Sodium. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| EQ 200MG BASE/2ML (EQ 100MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | Oct 4, 2023 |
| EQ 500MG BASE/5ML (EQ 100MG BASE/ML) | solution | Discontinued | INTRAVENOUS | N/A | Oct 4, 2023 |